TNFRSF8 and lymphoma: CD30 CARs have also been added to EBV-virus-specific T-cells, generating off-the-shelf allogeneic CD30-CAR EBVSTs capable of killing both CD30+ lymphoma cells and alloreactive T-cells [96].